Time course of activated coagulation time at various sites during continuous haemodiafiltration using nafamostat mesilate

Intensive Care Medicine

Volumn 25, Issue 5, 1999, Pages 524-527

  Hu, Z J ^a   Iwama, H ^a   Suzuki, R ^a   Kobayashi, S ^a   Akutsu, I ^a  

^a Central Aizu General Hospital   (Japan)

Author keywords

Activated coagulation time; Anticoagulation; Continuous haemodiafiltration; Haemofilter; Nafamostat mesilate; Polymethylmethacrylate

Indexed keywords

DIALYSIS FLUID; NAFAMSTAT MESILATE; POLY(METHYL METHACRYLATE); SODIUM CHLORIDE;

ADULT; AGED; ARTICLE; ARTIFICIAL MEMBRANE; BLOOD CLOTTING TIME; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; FLOW RATE; HEMOFILTRATION; HUMAN; INJECTION SITE; INTENSIVE CARE; INTRAARTERIAL DRUG ADMINISTRATION; MAJOR SURGERY; MALE; MULTIPLE ORGAN FAILURE; PRESSURE; SEPSIS; STATISTICAL ANALYSIS;

AGED; ANALYSIS OF VARIANCE; ANTICOAGULANTS; BLOOD COAGULATION TESTS; DRUG MONITORING; FEMALE; GUANIDINES; HEMODIAFILTRATION; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; WHOLE BLOOD COAGULATION TIME;

EID: 0033008890     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001340050892     Document Type: Article

References (10)

1. 1. Kox WJ, Rohr U, Wauer H (1996) Practical aspects of renal replacement therapy. Int J Artif Organs 19: 100-105
2. 2. Okajima K, Uchiba M, Murakami K (1995) Nafamostat mesilate. Cardiovasc Drugs Rev 13: 51-65
3. 3. Aoyama T (1984) Nafamostat mesilate. Drugs of the Future 9: 747-748
4. 4. Shanklin N, Ploth DW (1980) Evaluation of an activated clotting time technique for use in hemodialysis. Dialysis Transplant 9: 955-957
5. 5. Fujii S, Hitomi Y (1981) New synthetic inhibitors of C1r, C1 esterase, thrombin, plasmin, kallikrein and trypsin. Biochim Biophys Acta 661: 342-345
6. 6. Hitomi Y, Ikari N, Fujii S (1985) Inhibitory effect of a new synthetic protease inhibitor (FUT-175) on the coagulation system. Haemostasis 15: 164-168
7. 7. Koshiyama Y, Ozeki M, Motoyoshi A, Fujita M, Iwaki M, Aoyama T (1984) Pharmacological studies of FUT-175, nafamostat mesilate: IV. effects on coagulation, platelets and fibrinolysis (in Japanese with English abstract). Folia Pharmacol Japon 84: 417-428
8. 8. Iwama H, Nakane M, Ohmori S, Kaneko T, Kato M, Watanabe K, Okuaki A (1998) Nafamostat mesilate, a kallikrein inhibitor, prevents pain on injection with propofol. Br J Anaesth 81: 963-964
9. 9. Kubota T, Miyata A, Maeda A, Hirota K, Koizumi S, Ohba H (1997) Continuous haemodiafiltration during and after cardiopulmonary bypass in renal failure patients. Can J Anaesth 44: 1182-1186
10. 10. Hirasawa H, Sugai T, Ohtake Y, Oda S, Matsuda K, Kitamura N (1996) Blood purification for prevention and treatment of multiple organ failure. World J Surg 20: 482-486